SARS-CoV-2 Antigen kit

  • SARS-CoV-2 Antigen Rapid Test(Professional Use)

    SARS-CoV-2 Antigen Rapid Test(Professional Use)

    REF 500200 Specification  25 Tests/box
    Detection principle Immunochromatographic assay Specimens Anterior nasal swab
    Intended Use StrongStep® SARS-CoV-2 Antigen Rapid Test Cassette employs immunochromatography technology to detect the SARS- CoV-2 nucleocapsid antigen in human anterior nasal swab specimen. This testis single use only and intended for self-testing. It is recommanded to use this test within 5 days of symptom onset. It is supported by the clinical performance assessment.
  • SARS-CoV-2 Antigen Rapid Test(nasal)

    SARS-CoV-2 Antigen Rapid Test(nasal)

    REF 500200 Specification 1 Tests/Box ;5 Tests/box ; 20 Tests/box
    Detection principle Immunochromatographic assay Specimens Anterior nasal swab
    Intended Use StrongStep® SARS-CoV-2 Antigen Rapid Test Cassette employs immunochromatography technology to detect the SARS- CoV-2 nucleocapsid antigen in human anterior nasal swab specimen. This testis single use only and intended for self-testing. It is recommanded to use this test within 5 days of symptom onset. It is supported by the clinical performance assessment.

     

  • SARS-CoV-2 Antigen Rapid Test for Saliva

    SARS-CoV-2 Antigen Rapid Test for Saliva

    REF 500230 Specification 20 Tests/Box
    Detection principle Immunochromatographic assay Specimens
    Saliva
    Intended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Saliva swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19.
  • System Device for SARS-CoV-2 & Influenza A/B Combo Antigen Rapid Test

    System Device for SARS-CoV-2 & Influenza A/B Combo Antigen Rapid Test

    REF 500220 Specification 20 Tests/Box
    Detection principle Immunochromatographic assay Specimens Nasal / Oropharyngeal swab
    Intended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Nasal/Oropharyngeal swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19.
  • Dual Biosafety System Device for SARS-CoV-2 Antigen Rapid Test

    Dual Biosafety System Device for SARS-CoV-2 Antigen Rapid Test

    REF 500210 Specification 20 Tests/Box
    Detection principle Immunochromatographic assay Specimens Nasal / Oropharyngeal swab
    Intended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Nasal /Oropharyngeal swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19.